These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38837163)
21. Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients. Dobbins M; Rakkar M; Cunnane K; Pennypacker SD; Wagoner KG; Reboussin BA; Romero-Sandoval EA Front Public Health; 2022; 10():893009. PubMed ID: 35784239 [TBL] [Abstract][Full Text] [Related]
22. Development and Validation of a Simple, Fast, and Accessible HPLC-UV Method for Cannabinoids Determination in Silva Sofrás FM; Alonso R; Retta DS; Di Leo Lira P; Desimone MF; van Baren CM Curr Pharm Des; 2023; 29(24):1918-1928. PubMed ID: 37559239 [TBL] [Abstract][Full Text] [Related]
24. Clinicians' Guide to Cannabidiol and Hemp Oils. VanDolah HJ; Bauer BA; Mauck KF Mayo Clin Proc; 2019 Sep; 94(9):1840-1851. PubMed ID: 31447137 [TBL] [Abstract][Full Text] [Related]
25. On-label on the table: what the package insert informs us about the tolerability profile of oral atypical antipsychotics, and what it does not. Citrome L; Nasrallah HA Expert Opin Pharmacother; 2012 Aug; 13(11):1599-613. PubMed ID: 22017361 [TBL] [Abstract][Full Text] [Related]
27. The impacts of potency, warning messages, and price on preferences for Cannabis flower products. Shi Y; Cao Y; Shang C; Pacula RL Int J Drug Policy; 2019 Dec; 74():1-10. PubMed ID: 31382201 [TBL] [Abstract][Full Text] [Related]
28. Using Transformer-Based Topic Modeling to Examine Discussions of Delta-8 Tetrahydrocannabinol: Content Analysis. Smith BP; Hoots B; DePadilla L; Roehler DR; Holland KM; Bowen DA; Sumner SA J Med Internet Res; 2023 Dec; 25():e49469. PubMed ID: 38127427 [TBL] [Abstract][Full Text] [Related]
29. Commercial cannabis consumer products part 1: GC-MS qualitative analysis of cannabis cannabinoids. Ciolino LA; Ranieri TL; Taylor AM Forensic Sci Int; 2018 Aug; 289():429-437. PubMed ID: 29954632 [TBL] [Abstract][Full Text] [Related]
30. Analytical method validation for assay determination of cannabidiol and tetrahydrocannabinol in hemp oil infused products by RP-HPLC. Analakkattillam S; Langsi VK; Hanrahan JP; Moore E Sci Rep; 2022 Jul; 12(1):12453. PubMed ID: 35864137 [TBL] [Abstract][Full Text] [Related]
31. On offer to Ontario consumers three years after legalization: A profile of cannabis products, cannabinoid content, plant type, and prices. Tassone F; Di Ciano P; Liu Y; Rueda S Front Psychiatry; 2023; 14():1111330. PubMed ID: 36873222 [TBL] [Abstract][Full Text] [Related]
32. How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis. Myran DT; Staykov E; Cantor N; Taljaard M; Quach BI; Hawken S; Tanuseputro P Drug Alcohol Rev; 2022 Feb; 41(2):377-385. PubMed ID: 34250645 [TBL] [Abstract][Full Text] [Related]
33. FDA preemption of drug and device labeling: who should decide what goes on a drug label? Valoir T; Ghosh S Health Matrix Clevel; 2011; 21(2):555-98. PubMed ID: 22145525 [TBL] [Abstract][Full Text] [Related]
34. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada. Myran DT; Roberts R; Pugliese M; Taljaard M; Tanuseputro P; Pacula RL JAMA Netw Open; 2022 Sep; 5(9):e2231937. PubMed ID: 36112372 [TBL] [Abstract][Full Text] [Related]
35. Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products. Gibson LP; Mueller RL; Winiger EA; Klawitter J; Sempio C; Williams S; Bryan AD; Bidwell LC; Hutchison KE Cannabis Cannabinoid Res; 2024 Feb; 9(1):320-334. PubMed ID: 36378267 [No Abstract] [Full Text] [Related]
37. Health warning labels on cannabis products. What is the best design? Gantiva C; Illidge-Cortes J; González-Millares D; Maldonado-Hoyos V; Valencia L Int J Drug Policy; 2024 Apr; 126():104355. PubMed ID: 38382352 [TBL] [Abstract][Full Text] [Related]
38. Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries. Lenton S; Frank VA; Barratt MJ; Potter GR; Decorte T Drug Alcohol Depend; 2018 Nov; 192():250-256. PubMed ID: 30292153 [TBL] [Abstract][Full Text] [Related]
39. Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: a repeat cross-sectional study. Wadsworth E; Rynard V; Driezen P; Freeman TP; Rychert M; Wilkins C; Hall W; Gabrys R; Hammond D Harm Reduct J; 2023 Feb; 20(1):19. PubMed ID: 36803833 [TBL] [Abstract][Full Text] [Related]